Literature DB >> 16487488

FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues.

Jeffry R Cook1, Jin-Hyung Lee, Zhi-Hong Yang, Christopher D Krause, Nicole Herth, Ralf Hoffmann, Sidney Pestka.   

Abstract

We have identified a protein, FLJ12673 or FBXO11, that contains domains characteristically present in protein arginine methyltransferases (PRMTs). Immuno-purified protein expressed from one of the four splice variants in HeLa cells and in Escherichia coli exhibited methyltransferase activity. Monomethylarginine, symmetric, and asymmetric dimethylarginine (SDMA, ADMA) were formed on arginine residues. Accordingly, we have designated the protein PRMT9. PRMT9 is the third member of the PRMT family that forms SDMA modifications in proteins. Structurally, this protein is distinct from all other known PRMTs implying that convergent evolution allowed this protein to develop the ability to methylate arginine residues and evolved elements conserved in PRMTs to accomplish this.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487488     DOI: 10.1016/j.bbrc.2006.01.167

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  50 in total

1.  CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells.

Authors:  Karen B O'Brien; Meritxell Alberich-Jordà; Neelu Yadav; Olivier Kocher; Annalisa Diruscio; Alexander Ebralidze; Elena Levantini; Natasha J L Sng; Manoj Bhasin; Tyler Caron; Daehoon Kim; Ulrich Steidl; Gang Huang; Balázs Halmos; Scott J Rodig; Mark T Bedford; Daniel G Tenen; Susumu Kobayashi
Journal:  Development       Date:  2010-07       Impact factor: 6.868

Review 2.  Histone arginine methylation.

Authors:  Alessandra Di Lorenzo; Mark T Bedford
Journal:  FEBS Lett       Date:  2010-11-11       Impact factor: 4.124

Review 3.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

Review 4.  Protein arginine methyltransferases: from unicellular eukaryotes to humans.

Authors:  François Bachand
Journal:  Eukaryot Cell       Date:  2007-04-27

5.  Clinical evaluation of PRMT1 gene expression in breast cancer.

Authors:  Konstantina Mathioudaki; Andreas Scorilas; Alexandros Ardavanis; Peggy Lymberi; Evangelos Tsiambas; Marina Devetzi; Aikaterini Apostolaki; Maroulio Talieri
Journal:  Tumour Biol       Date:  2011-01-13

Review 6.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

7.  PRMTs and miRNAs: functional cooperation in cancer and beyond.

Authors:  Jiamin Jin; Matthew Martin; Antja-Voy Hartley; Tao Lu
Journal:  Cell Cycle       Date:  2019-06-24       Impact factor: 4.534

Review 8.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

9.  Mutations in the Type II protein arginine methyltransferase AtPRMT5 result in pleiotropic developmental defects in Arabidopsis.

Authors:  Yanxi Pei; Lifang Niu; Falong Lu; Chunyan Liu; Jixian Zhai; Xiangfeng Kong; Xiaofeng Cao
Journal:  Plant Physiol       Date:  2007-06-15       Impact factor: 8.340

10.  Regulation of TGF-beta signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant.

Authors:  Hilda Tateossian; Rachel E Hardisty-Hughes; Susan Morse; Maria R Romero; Helen Hilton; Charlotte Dean; Steve Dm Brown
Journal:  Pathogenetics       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.